Blood Glucose Monitoring System Market - Trends Forecast Till 2028

Blood Glucose Monitoring System Market, By Product (Self-Monitoring Blood Glucose Systems, Continuous Glucose Monitoring Systems, Insulin Drug Delivery Devices), Testing Site (Alternate Site Testing, Fingertip Testing), Connectivity Technology (Biosensors, Bluetooth-Enabled, Smartphone Based Glucometers, Others), Advanced Devices (Smart Contact Lenses, Laser Based System, Earlobe Devices, Saliva Analyzers, Wearables, Others), Patient Care Setting (Hospitals & Clinics, Home Care), Application (Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes) Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Published Date: September, 2020

Base Year Estimate: 2019

Report ID: D-HC-BGMSM-27

Format:  

Number of Pages: 327

Domain: Healthcare

Blood Glucose Monitoring System Market – Trends Forecast Till 2028

The global blood glucose monitoring system market is anticipated to reach USD 11.7 billion by 2020 growing at a CAGR of 5.2% during the forecasting period, 2020-2028. Blood glucose monitoring systems are the diagnostic systems that are necessary for the care & treatment of diabetes which is used for measuring and monitoring the levels of blood sugar in patients. Factors such as the growing prevalence of diabetes and the rising number of product launches are some of the major drivers for the market of blood glucose monitoring system

Blood Glucose Monitoring System Market – Trends Forecast Till 2028

The global blood glucose monitoring system market is segmented into modality products, testing sites, connectivity technology, advanced devices, patient care setting, application, and geography.

The product segment is segmented into self-monitoring blood glucose systems, continuous glucose monitoring systems, insulin drug delivery devices. Self-Monitoring Blood Glucose Systems is further segmented into testing strips, blood glucose meters, lancets & lancing devices. The continuous Glucose Monitoring Systems segment is further segmented into transmitters, sensors, receivers. The Insulin Drug Delivery Devices segment is further segmented into insulin syringes, insulin pens, insulin pumps, insulin jet injectors.

Testing Site segment is segmented into Alternate Site Testing, Fingertip Testing

On the basis of the testing site, the fingertip testing segment is expected to dominate the market for blood glucose monitoring systems during the forecast period 2020-2028

The connectivity technology segment is segmented into Biosensors, Bluetooth-Enabled, Smartphone-Based Glucometers, Others

Advanced devises segment is segmented into Smart Contact Lenses, Laser-Based System, Earlobe Devices, Saliva Analyzers, Wearables, Others

Patient Care Setting segment is segmented into Hospitals & Clinics, Home Care

The application segment is segmented into Type 2 Diabetes, Type 1 Diabetes, and Gestational Diabetes. Type 2 diabetes is further segmented into adults and pediatrics. Type 1 diabetes is further segmented into adults and pediatrics.

Geographically, the global blood glucose monitoring system market is sub-segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions.

North America region is the largest contributor to the blood glucose monitoring system market in the forecast period 2020-2028.

Key players in global blood glucose monitoring system market F. Hoffmann-LA Roche Ltd, Abbott, Thermo Fisher Scientific Inc., Siemens AG, Bio-Rad Laboratories, Inc., BD, Beckman Coulter, Inc., Biomérieux SA, Cepheid (A Subsidiary Of Danaher Corporation), Enzo Biochem Inc., Grifols International, S.A., Hologic Inc., Immucor, Inc., Meridian Bioscience, Inc., Ortho Clinical Diagnostics among others

The companies have come up with various promotional activities in from of launch, investment, acquisition, and other, for instance:

  • In 2018, Medtronic has received FDA approval for a continuous glucose monitoring system in people with diabetes aged between 14-75 years, called Guardian Connect.
  • In 2017, Abbott has received FDA approval for FreeStyle Libre Flash its revolutionary blood glucose monitoring device that doesn't require finger pricking, instead it required a sensor to be worn underneath the skin that could be used for 10 days and for continuous monitoring.

Available Customizations

In addition to the market data for the blood glucose monitoring system market, Delvens. offers client-centric reports and customized according to the company’s specific demand and requirement.

Research Methodology

Secondary Research

This research method involved the usage of extensive secondary sources (such as directories and databases)—Hoovers, Avention, annual reports, investor presentation, a conference like Jefferies conference)—to identify and collect information useful for this study of the blood glucose monitoring system market. The purpose of secondary research is to identify and collection of extensive, technical, market-oriented, and commercial studies of the global blood glucose monitoring system market. Through secondary, the market is classified and segmented as per industry trends, developments, regional markets, products, and technological developments.

Primary Research

The primary sources mainly included several industry experts from the core and related industries and suppliers, manufacturers, distributors, alliances, and organizations related to all segments of this industry’s supply chain. In-depth interviews were conducted with various primary respondents—including key industry participants, subject matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts—to obtain and verify critical qualitative and quantitative information as well as to assess future prospects. The following figure depicts the market research methodology used in drafting this report on the blood glucose monitoring system market.

The primary Respondent breakdown is provided below:

Blood Glucose Monitoring System Market – Trends Forecast Till 2028

Market Sizing

Top-down and bottom approaches were used to derive the market estimate and validate the total revenue of the blood glucose monitoring system market. This approach has also been used to derive the market for segmentation and sub-segmentation.

Data Validation

Impact analysis has been conducted for deriving the market size. After collecting the in-depth quantitative and qualitative data, we contact the primary respondents in order to gain a 98.8% of confidence level on our data.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Reasons to Acquire

  • Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors
  • Gain authentic and granular data access for the blood glucose monitoring market so as to understand the trends and the factors involved in changing market situations
  • Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
  • In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope

 

Report Features

Description

Market Revenue In 2020

USD 11.7 billion

Growth Rate

CAGR of 5.2% during the forecasting period, 2020-2028

Historical Data

2017-2018

Forecast Years

2020-2028

Base Year

2019

Units Considered

Revenue in USD billion and CAGR from 2020 to 2028

Report Segmentation

Modality Products, Testing Site, Connectivity Technology, Advanced Devices, Patient Care Setting, Application and Geography

Report Attribute

Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling

Regional Level Scope

North America, Europe, Asia-Pacific, South America, and the Middle East and Africa

Country Level Scope

U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe)

Companies Profiled

F. Hoffmann-LA Roche Ltd, Abbott, Thermo Fisher Scientific Inc., Siemens AG, Bio-Rad Laboratories, Inc., BD, Beckman Coulter, Inc., Biomérieux SA, Cepheid (A Subsidiary Of Danaher Corporation), Enzo Biochem Inc., Grifols International, S.A., Hologic Inc., Immucor, Inc., Meridian Bioscience, Inc., Ortho Clinical Diagnostics among others

Available Customization

In addition to the market data for the blood glucose monitoring system market, Delvens offers client-centric reports and customized according to the company’s specific demand and requirement.

 

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Choose License Type
Global: 50+ Countries

Note: Report data and information will be by Country.


Regional Report

Note: Report data and information will be by Country.


Country Specific Report

Bundle Reports

50% Discount on all additional reports  

Special Pricing

Avail customised purchase options to meet your specific research requirements.

Custom Tailored Services

Delvens. offers transformed research reports where syndicated reports are not sufficient to provide solutions to your business.

Subscription Model

Get latest and trending updates throughout the year on the reports you buy.